![]() |
|
|
Forward to a colleague |
||
Product Overview ![]() Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here Access Full Stories New data have raised 'serious questions' about whether Arpida's new antibiotic will be approved by industry regulators, according to one analyst's report... Read Big pharma learning drug safety lessons Big pharma is learning from past failures to improve its ability to predict drug toxicity earlier in the development process... Read Nicholas Piramal to spin off R&D unit Nicholas Piramal is the latest Indian pharma firm planning to spin off its new chemical entity (NCE) research unit as its pipeline is maturing... Read MicroCal pushes ITC towards secondary screening applications The launch of the world's fastest isothermal titration calorimeter (ITC) could herald a new dawn for a technique traditionally hampered by throughput limitations and the need for large amounts of sample... Read R&D news in brief In a round up of the latest news in pharma research, Pfizer and Bristol-Myers Squibb have big plans for DGAT-1 in obesity and diabetes, GlaxoSmithKline is extra keen on Exelixis' anticancer drug, Takeda is talking... Read |
||||||||||
All News Headlines for: August | July | June |
||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Sanofi-Aventis faces a second patent lawsuit for SoloStar Sanofi-Aventis has been hit with its second patent lawsuit in two months over its recently released SoloStar insulin pen... Read Synthetic MAb purification tech edges closer to market The UK arm of biopharma company ProMetic has hit a milestone with its breakthrough synthetic molecule solution for protein purification... Read First US cell-based flu vaccine plant underway Novartis last week began construction of a major new flu vaccine manufacturing facility in North Carolina, the very first cell culture-derived flu vaccine plant in the United States... Read Indian drug manufacturers must clean up their act New research has branded pharmaceutical manufacturers in India as being responsible for the release of substantial and worrying amounts of active pharmaceutical ingredients (APIs) into the environment... Read
|
||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||